Medicare Enrolled
Dr. Brian McDonald, MD
Pulmonary Disease · Schenectady, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. McDonald from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. McDonald?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. McDonald
Dr. Brian McDonald is a pulmonary disease specialist in Schenectady, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. McDonald performed 1,455 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. McDonald received a total of $12,515 from 50 pharmaceutical and/or device companies across 518 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. McDonald is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 29% volume in NY
$12,515 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,455
Medicare services
Top 29% in NY for pulmonary disease
Not available
Unique patients (not deduplicated)
$88
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
586 | $93 | $196 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
245 | $92 | $207 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
124 | $167 | $399 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
73 | $40 | $95 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
72 | $43 | $98 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
71 | $64 | $143 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
68 | $136 | $376 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
63 | $29 | $124 |
| Virtual check-in for established patient A brief communication service provided by a qualified healthcare professional to an established patient via technology, such as a virtual check-in. |
51 | $10 | $22 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
32 | $26 | $177 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
25 | $90 | $207 |
| New patient office visit, complex (60-74 min) | 18 | $160 | $386 |
| Additional 30 minutes of critical care This code represents an additional 30 minutes of critical care services provided beyond the initial critical care time period. |
16 | $84 | $191 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
11 | $19 | $62 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$12,515
Total received (2018-2024)
Avg $1,788/year across 7 years
Top 15% in NY for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
518
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,672
2023
$1,946
2022
$1,636
2021
$1,504
2020
$991
2019
$1,579
2018
$1,187
Payments by company (2024)
INTUITIVE SURGICAL, INC.
$1,641
AstraZeneca Pharmaceuticals LP
$489
Harmony Biosciences Llc
$172
Boehringer Ingelheim Pharmaceuticals, Inc.
$169
GlaxoSmithKline, LLC.
$145
ABBVIE INC.
$145
Regeneron Healthcare Solutions, Inc.
$125
Merck Sharp & Dohme LLC
$124
GENZYME CORPORATION
$115
Philips North America LLC
$93
Baxter Healthcare
$77
HARMONY BIOSCIENCES LLC
$69
Insmed, Inc.
$60
Amgen Inc.
$52
JAZZ PHARMACEUTICALS INC.
$50
Pulmonx Corporation
$44
Actelion Pharmaceuticals US, Inc.
$43
Novartis Pharmaceuticals Corporation
$23
Grifols USA, LLC
$22
Shionogi Inc
$14
Top 3 companies account for 62.7% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,654
INTUITIVE SURGICAL, INC.
$1,641
GlaxoSmithKline, LLC.
$1,594
Boehringer Ingelheim Pharmaceuticals, Inc.
$957
Pulmonx Corporation
$656
GENZYME CORPORATION
$460
Astellas Pharma US Inc
$378
Genentech USA, Inc.
$367
Ethicon Inc.
$318
Regeneron Healthcare Solutions, Inc.
$306
Janssen Pharmaceuticals, Inc
$260
Novartis Pharmaceuticals Corporation
$254
ABBVIE INC.
$249
Grifols USA, LLC
$240
Electromed, Inc.
$230
Harmony Biosciences LLC
$210
Philips Electronics North America Corporation
$199
Insmed, Inc.
$195
Merck Sharp & Dohme LLC
$194
Merck Sharp & Dohme Corporation
$174
Harmony Biosciences Llc
$172
PFIZER INC.
$161
Actelion Pharmaceuticals US, Inc.
$130
Shire North American Group Inc
$126
Amgen Inc.
$123
Baxter Healthcare
$122
Mylan Specialty L.P.
$119
Takeda Pharmaceuticals U.S.A., Inc.
$106
Philips North America LLC
$93
HARMONY BIOSCIENCES LLC
$89
JAZZ PHARMACEUTICALS INC.
$73
PORTOLA PHARMACEUTICALS, INC.
$72
United Therapeutics Corporation
$66
Circassia Pharmaceuticals Inc
$62
Mallinckrodt Hospital Products Inc.
$56
Shionogi Inc
$53
Covidien LP
$45
Alexion Pharmaceuticals, Inc.
$45
Teva Pharmaceuticals USA, Inc.
$42
Gilead Sciences, Inc.
$37
Mallinckrodt LLC
$26
CSL Behring
$24
Bayer HealthCare Pharmaceuticals Inc.
$23
ABIOMED
$22
Advanced Respiratory, Inc
$20
ADVANCED RESPIRATORY, INC
$18
Veran Medical Technologies, Inc.
$14
Ambu Inc.
$14
PORTOLA PHARMACEUTICALS, LLC
$12
E.R. Squibb & Sons, L.L.C.
$12
Top 3 companies account for 39.1% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSUPRA · AMBISOME · ANDEXXA · ANORO ELLIPTA · AVYCAZ · Adempas · Arikayce · BEVYXXA · BREO · BREZTRI · BREZTRI AEROSPHERE · CHANTIX · CHARTIS CATHETER · CRESEMBA · DIFICID · DUPIXENT · Da Vinci Surgical System · ELIQUIS · Esbriet · FARXIGA · FASENRA · Fetroja · GLASSIA · Hillrom - Life 2000 Ventilation System · Hillrom - Monarch Airway Clearance System · Hillrom - Vest System Model 105 Home Care · Hillrom - VisiVest Airway Clearance System · Hizentra · Impella · KEYTRUDA · Life 2000 Ventilation System · MYCAMINE · Monarch Platform · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · ORENITRAM · PREVNAR - 13 · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · QVAR · SMARTVEST · SOLIRIS · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Spin · SuperDimension · TEFLARO · TERLIVAZ · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · Trilogy 100 · UPTRAVI · Ultomiris · WAKIX · Wakix · Wellcentive Undiv · XARELTO · XOLAIR · XYWAV · Xolair · YUPELRI · Yupelri · ZERBAXA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pulmonary diseases in nearby ZIP areas
37
County median income
$76,989
Nearest hospital to ZIP centroid (approximate)
ELLIS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. McDonald is a clinical cardiology specialist, with above-average Medicare volume (top 29% in NY), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. McDonald experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. McDonald performed 586 hospital follow-up visit, high complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. McDonald receive payments from pharmaceutical companies?
Yes. Dr. McDonald received a total of $12,515 from 50 companies across 518 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. McDonald's costs compare to other pulmonary diseases in Schenectady?
Dr. McDonald's average Medicare payment per service is $88. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. McDonald) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Schenectady
Browse pulmonary diseases in Schenectady ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in NY
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in NY
Which NY pulmonary diseases receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
INTUITIVE SURGICAL, INC. Payments to Doctors
See all physicians who received payments from INTUITIVE SURGICAL, INC.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology